Vahedi M, Abdollahzadeh
S, Vaziri PB, Mortazavi H.
Oral contraceptive use and salivary C-erbB-2, CEA and CA15-3 in healthy women:
A Case-Control Study. Med Oral Patol Oral Cir Bucal. 2011 Jan 1;16 (1):e29-32.
doi:10.4317/medoral.16.e29
1. Westhoff CL, Heartwell S, Edwards
S, Zieman M, Stuart G, Cwiak C, et al. Oral contraceptive discontinuation:
do side effects matter? Am J Obstet Gynecol. 2007;196:412.e1-6.
2. McIntyre R, Bigler L, Dellinger T, Pfeifer M, Mannery T, Streckfus C. Oral
contraceptive usage and the expression of CA 15-3 and c-erbB-2 in the saliva of
healthy women. Oral Surg Oral Med
Oral Pathol Oral Radiol Endod. 1999;88:687-90.
doi:10.1016/S1079-2104(99)70011-9
3. Biglia N, Mariani L, Sgro L, Mininanni P, Moggio G, Sismondi P. Increased incidence of lobular breast
cancer in women treated with hormone replacement therapy: implications for
diagnosis, surgical and medical treatment. Endocr Relat
Cancer. 2007;14:549-67.
doi:10.1677/ERC-06-0060
PMid:17914088
4. Lester J. Breast cancer in 2007: incidence, risk assessment, and risk
reduction strategies. Clin J Oncol
Nurs. 2007;11:619-22.
doi:10.1188/07.CJON.619-622
PMid:17962169
5. Emekli-Alturfan E, Demir
G, Kasikci E, Tunali-Akbay
T, Pisiriciler R, Caliskan
E, et al. Altered biochemical parameters in the saliva of patients with breast
cancer. Tohoku J Exp Med. 2008;214:89-96.
doi:10.1620/tjem.214.89
PMid:18285665
6. Ross JS, Fletcher JA. The HER-2/neu
Oncogene in Breast Cancer: Prognostic Factor,
Predictive Factor, and Target for Therapy. Oncologist.
1998;3:237-52.
PMid:10388110
7. Streckfus CF, Bigler L,
Dellinger T, Kuhn M, Chouinard N, Dai X. The expression of the c-erbB-2 receptor protein in glandular
salivary secretions. J Oral Pathol Med. 2004;33:595-600.
doi:10.1111/j.1600-0714.2004.00255.x
PMid:15482325
8. Streckfus C, Bigler L,
Dellinger T, Dai X, Cox WJ, McArthur A, et al. Reliability assessment of
soluble c-erbB-2 concentrations in the saliva of healthy women and men. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:174-9.
doi:10.1067/moe.2001.111758
9. Agha-Hosseini F,
Mirzaii-Dizgah I, Rahimi A.
Correlation of serum and salivary CA15-3 levels in patients with breast cancer.
Med
Oral Patol Oral Cir Bucal. 2009;14:e521-4.
doi:10.4317/medoral.14.e521
10. Guadagni F, Ferroni P, Carlini
S, Mariotti S, Spila A,
Aloe S, et al. A re-evaluation of carcinoembryonic
antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal
study. Clin Cancer Res. 2001;7:2357-62.
PMid:11489813
11. Streckfus C, Bigler L,
Dellinger T, Pfeifer M, Rose A, Thigpen JT. CA 15-3 and c-erbB-2 presence in
the saliva of women. Clin Oral Investig. 1999;3:138-43.
doi:10.1007/s007840050092
PMid:10803125
12. Navazesh M; ADA Council on Scientific Affairs and Division of Science.
How can oral health care providers determine if patients have dry mouth? J Am
Dent Assoc. 2003;134:613-20.
PMid:12785497
13. Dumeaux V, Fournier A, Lund E, Clavel-Chapelon
F. Previous oral contraceptive use and breast cancer
risk according to hormone replacement therapy use among postmenopausal women.
Cancer Causes Control. 2005;16:537-44.
doi:10.1007/s10552-004-8024-z
14. Kahlenborn C, Modugno
F, Potter DM, Severs WB. Oral contraceptive use as a risk factor for
premenopausal breast cancer: a meta-analysis. Mayo Clin
Proc. 2006;81:1290-302.
doi:10.4065/81.10.1290
PMid:17036554
15. Hankinson SE, Colditz GA, Willett WC. Towards an
integrated model for breast cancer etiology: the lifelong interplay of genes,
lifestyle, and hormones. Breast Cancer Res. 2004;6:213-8.
doi:10.1186/bcr921
PMid:15318928 PMCid:549181
16. Molina R, Filella X, Zanon G, Pahisa J, Alicarte J, Munoz M, et al. Prospective evaluation of tumor
markers (c-erbB-2 oncoprotein, CEA and CA 15.3) in
patients with locoregional breast cancer. Anticancer Res. 2003;23:1043-50.
PMid:12820345
17. Molina R, Jo J, Filella X, Zanón
G, Farrus B, Muñoz M, et al. C-erbB-2, CEA and CA 15.3 serum levels in the early
diagnosis of recurrence of breast cancer patients. Anticancer
Res. 1999;19:2551-5.
PMid:10470193
18. Molina R, Jo J, Filella X, Zanon
G, Pahisa J, Munoz M, et
al. C-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast
cancer: prognostic value. Breast Cancer Res Treat. 1998;51:109-19.
doi:10.1023/A:1005734429304
PMid:9879773
19. Schipper RG, Silletti E,
Vingerhoeds MH. Saliva as research material:
biochemical, physicochemical and practical aspects. Arch Oral Biol. 2007;52:1114-35.
doi:10.1016/j.archoralbio.2007.06.009
PMid:17692813
20. Nieuw Amerongen AV, Ligtenberg
AJ, Veerman EC. Implications for diagnostics in the
biochemistry and physiology of saliva. Ann N Y Acad
Sci. 2007;1098:1-6.
doi:10.1196/annals.1384.033
PMid:17303829